Wolfgang Wienand
SwitzerlandbusinessmanMale7.0Global Dominance: 0.00%Wolfgang Wienand is the CEO of Lonza, a leading global contract manufacturer of pharmaceuticals. Under his leadership, Lonza has emphasized its ability to pass on potential tariffs from the U.S. to its pharmaceutical clients, which could impact drug pricing in the U.S. market. The company has also made significant investments to expand its manufacturing capabilities, including a recent acquisition of a biotech facility in California.
Country presence
Recent news mentions
Wolfgang Wienand is the CEO of Lonza and discussed the company's strategies during the half-year conference.
Lonza wittert in den USA Chancen wegen Zöllen auf GenerikaSwitzerland· 2026-07-22
Wolfgang Wienand is the CEO of Lonza and mentioned the company's future investment plans.
Lonza investiert künftig lieber anderswo als in der SchweizSwitzerland· 2026-01-29
Wolfgang Wienand is the CEO of Lonza, who stated that the company would pass any potential tariffs onto its pharmaceutical customers.
Kunden setzen Schweizer Pharmahersteller wegen Zöllen unter DruckSwitzerland· 2025-09-01
